InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AC Immune SA

ACIU Clue Score16
Switzerland Fiscal year ends December CIK 0001651625
$2.50 -1.96% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.50 −60.94% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue23.2Operating income−10.5Net income−7.1EPS, diluted−0.14Fiscal year 2017Revenue20.3 −12.7%Operating income−22.5Net income−26.4EPS, diluted−0.46Fiscal year 2018Revenue6.9 −65.9%Operating income−49.6Net income−51.0EPS, diluted−0.82Fiscal year 2019Revenue110.5 +1,498.0%Operating income44.5Net income45.4EPS, diluted0.64Fiscal year 2020Revenue15.4 −86.0%Operating income−61.3Net income−61.9 −236.3%EPS, diluted−0.86 −234.4%Fiscal year 2021Revenue0.0 −100.0%Operating income−79.0Net income−73.0EPS, diluted−0.97Fiscal year 2022Revenue3.9Operating income−70.8Net income−70.8EPS, diluted−0.85Fiscal year 2023Revenue14.8 +276.1%Operating income−53.6Net income−54.2EPS, diluted−0.64Fiscal year 2024Revenue27.3 +84.5%Operating income−52.4Net income−50.9EPS, diluted−0.51Fiscal year 2025Revenue3.6 −86.9%Operating income−69.3Net income−70.4EPS, diluted−0.70
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 23.2 20.3 6.9 110.5 15.4 0.0 3.9 14.8 27.3 3.6
Growth −12.7% −65.9% +1,498.0% −86.0% −100.0% +276.1% +84.5% −86.9%
Operating income −10.5 −22.5 −49.6 44.5 −61.3 −79.0 −70.8 −53.6 −52.4 −69.3
Net income −7.1 −26.4 −51.0 45.4 −61.9 −73.0 −70.8 −54.2 −50.9 −70.4
Growth −236.3%
EPS, diluted −0.14 −0.46 −0.82 0.64 −0.86 −0.97 −0.85 −0.64 −0.51 −0.70
Growth −234.4%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−45.0%Net margin−30.6%Free cash flow margin−28.2%Fiscal year 2017Operating margin−111.3%Net margin−130.4%Free cash flow margin−118.0%Fiscal year 2018Operating margin−716.9%Net margin−737.1%Free cash flow margin−664.6%Fiscal year 2019Operating margin40.3%Net margin41.1%Free cash flow margin48.3%Fiscal year 2020Operating margin−397.0%Net margin−401.3%Free cash flow margin−396.8%Fiscal year 2021Fiscal year 2022Operating margin−1,800.4%Net margin−1,798.0%Free cash flow margin−1,901.1%Fiscal year 2023Operating margin−362.3%Net margin−366.4%Free cash flow margin−413.5%Fiscal year 2024Operating margin−191.8%Net margin−186.4%Free cash flow margin239.0%Fiscal year 2025Operating margin−1,940.1%Net margin−1,971.6%Free cash flow margin−1,963.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −45.0% −111.3% −716.9% 40.3% −397.0% n/a −1,800.4% −362.3% −191.8% −1,940.1%
Net margin −30.6% −130.4% −737.1% 41.1% −401.3% n/a −1,798.0% −366.4% −186.4% −1,971.6%
Free cash flow margin −28.2% −118.0% −664.6% 48.3% −396.8% n/a −1,901.1% −413.5% 239.0% −1,963.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−5.6Capital expenditure−0.9Free cash flow−6.5Fiscal year 2017Operating cash flow−22.1Capital expenditure−1.8Free cash flow−23.9Fiscal year 2018Operating cash flow−44.1Capital expenditure−1.9Free cash flow−45.9Buybacks0.0Fiscal year 2019Operating cash flow55.2Capital expenditure−1.9Free cash flow53.3Buybacks0.0Fiscal year 2020Operating cash flow−59.5Capital expenditure−1.7Free cash flow−61.2 −214.8%Buybacks−0.1Fiscal year 2021Operating cash flow−65.7Capital expenditure−2.6Free cash flow−68.3Buybacks0.0Fiscal year 2022Operating cash flow−73.6Capital expenditure−1.2Free cash flow−74.8Buybacks0.0Fiscal year 2023Operating cash flow−60.4Capital expenditure−0.8Free cash flow−61.2Fiscal year 2024Operating cash flow65.8Capital expenditure−0.6Free cash flow65.3Fiscal year 2025Operating cash flow−69.3Capital expenditure−0.9Free cash flow−70.2 −207.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.6 −22.1 −44.1 55.2 −59.5 −65.7 −73.6 −60.4 65.8 −69.3
Capital expenditure −0.9 −1.8 −1.9 −1.9 −1.7 −2.6 −1.2 −0.8 −0.6 −0.9
Free cash flow −6.5 −23.9 −45.9 53.3 −61.2 −68.3 −74.8 −61.2 65.3 −70.2
Growth −214.8% −207.5%
Buybacks n/a n/a 0.0 0.0 −0.1 0.0 0.0 n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash152.2Shareholders’ equity142.4Fiscal year 2017Cash124.4Shareholders’ equity116.8Fiscal year 2018Cash156.5Shareholders’ equity177.6Fiscal year 2019Cash193.6Shareholders’ equity272.4Fiscal year 2020Cash160.9Shareholders’ equity215.5Fiscal year 2021Cash82.2Shareholders’ equity232.0Fiscal year 2022Cash31.6Shareholders’ equity169.0Fiscal year 2023Cash78.5Shareholders’ equity160.6Fiscal year 2024Cash36.3Shareholders’ equity112.3Fiscal year 2025Cash26.8Shareholders’ equity44.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 152.2 124.4 156.5 193.6 160.9 82.2 31.6 78.5 36.3 26.8
Shareholders’ equity 142.4 116.8 177.6 272.4 215.5 232.0 169.0 160.6 112.3 44.9

In millions of CHF, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of CHF, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
23.2 20.3 6.9 110.5 15.4 0.0 3.9 14.8 27.3 3.6
Growth −12.7% −65.9% +1,498.0% −86.0% −100.0% +276.1% +84.5% −86.9%
25.8 32.7 44.3 50.4 59.5 62.3 60.3 54.6 62.6 56.4
7.9 10.1 12.5 16.1 18.6 17.9 15.8 15.3 17.3 16.1
−10.5 −22.5 −49.6 44.5 −61.3 −79.0 −70.8 −53.6 −52.4 −69.3
Growth −237.6%
−7.1 −26.4 −51.0 45.4 −61.9 −73.0 −70.7 −54.2 −50.9 −70.4
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−7.1 −26.4 −51.0 45.4 −61.9 −73.0 −70.8 −54.2 −50.9 −70.4
Growth −236.3%
Per share
−0.14 −0.46 −0.82 0.64 −0.86 −0.97 −0.85 −0.64 −0.51 −0.70
−0.14 −0.46 −0.82 0.64 −0.86 −0.97 −0.85 −0.64 −0.51 −0.70
Growth −234.4%
50.1 57.1 61.8 70.6 71.9 75.0 83.6 84.7 99.7 100.8
50.1 57.1 61.8 71.1 71.9 75.0 83.6 84.7 99.7 100.8
Growth +13.9% +8.3% +15.0% +1.1% +4.2% +11.5% +1.4% +17.7% +1.1%

Shown in CHF as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 25.4% a year over five years.
  • The diluted share count rose 40.1% in five years, which is dilution.
  • Operating margin is down 1,543.1 points on five years ago, at -1,940.1%.
  • A net loss in 9 of 10 years on file.